Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM

NCT03673826 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Smouldering Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Dexamethasone
DRUG: Lenalidomide

Sponsor

Stichting Hemato-Oncologie voor Volwassenen Nederland